Vice President, Investor Relations at Ascendis Pharma A/S. Joining me on the call today are Jan Moller Mikkelsen, President ...
Share Repurchases -- 2.4 million shares repurchased at an average price of $40.94 per share in Q4 for $97 million, and ...
Q2 2026 Earnings Call February 25, 2026 7:30 PM ESTCompany ParticipantsJohn Welborn - Executive ChairmanChristopher Hunt ...
Q4 2025 Earnings Call February 26, 2026 4:00 AM ESTCompany ParticipantsLorea Aristizabal - Director of Corporate ...
As you saw in our Q4 results, and in the most recent shareholder letter, we ended the fiscal year with a strong first full ...
Transocean Ltd. (NYSE:RIG) Q4 2025 Earnings Call Transcript February 20, 2026 Operator: Thank you for your continued patience ...
Operator: Good day, and welcome to InfuSystem Holdings, Inc. Reports Fourth Quarter Fiscal Year 2025 Financial Results ...
JBT Marel Corporation (NYSE: JBT) Q4 2025 Earnings Call Transcript February 24, 2026 ...
Jack in the Box Inc. (NASDAQ:JACK) Q1 2026 Earnings Call Transcript February 18, 2026 Jack in the Box Inc. misses on earnings ...
Forward-looking statements are accurate only as of the date they are made, and Ceragon undertakes no obligation to update them. Ceragon's public filings are available on the Securities and Exchange ...
The CEO stated, "rough guess 15% to 20% of our business may be exposed to it," and emphasized the risk as "a moving target" that may increase, particularly in the Commercial segment. Adjusted free ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results